Zekai Shu
Overview
Explore the profile of Zekai Shu including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
6
Citations
70
Followers
0
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Dong B, Zhu X, Shu Z, Ji Y, Lu F, Wang J, et al.
Front Oncol
. 2020 Nov;
10:585709.
PMID: 33244457
Background: Compared the overall outcomes of video-assisted thoracoscopic surgery (VATS) stereotactic body radiotherapy (SBRT) for stage I-II non-small cell lung cancer (NSCLC). Methods: We retrospectively compared overall survival (OS), cancer-specific...
2.
Shu Z, Zeng Z, Yu B, Huang S, Hua Y, Jin T, et al.
Front Oncol
. 2020 Nov;
10:594687.
PMID: 33240818
Background And Aims: Malnutrition is a concern in patients with nasopharyngeal carcinoma (NPC) during chemoradiotherapy (CRT)/radiotherapy (RT), which is considered to be related with radiation-induced oral mucositis (ROM). The study...
3.
Shu Z, Dong B, Shi L, Shen W, Hang Q, Wang J, et al.
J Cancer Res Clin Oncol
. 2020 Nov;
147(10):3139.
PMID: 33230584
No abstract available.
4.
Huang S, Piao Y, Cao C, Chen J, Sheng W, Shu Z, et al.
Oral Oncol
. 2020 Oct;
111:105025.
PMID: 33032180
Objectives: We investigated the effect of prophylactic oral nutrition supplements (ONS) in locally advanced nasopharyngeal carcinoma patients receiving neoadjuvant chemotherapy and concurrent chemoradiotherapy (CCRT). Methods: Eligible patients were randomly assigned...
5.
Shu Z, Dong B, Shi L, Shen W, Hang Q, Wang J, et al.
J Cancer Res Clin Oncol
. 2020 Feb;
146(5):1263-1271.
PMID: 32095885
Purpose: Stereotactic body radiotherapy (SBRT) is the primary treatment method for early-stage non-small cell lung cancer (NSCLC) considered inoperable due to medical comorbidities. However, the application of SBRT in patients...
6.
Shu Z, Li P, Yu B, Huang S, Chen Y
Oral Oncol
. 2020 Jan;
102:104559.
PMID: 31923856
Oral mucositis (OM) is a common and troublesome adverse side effect of many cancer therapy modalities (chemotherapy, radiotherapy, and chemo-radiotherapy), which can cause pain, ulceration, dysphagia, malnutrition, even treatment interruption....